TherapeuticsMD, Inc. (TXMD): Gross Profit
Older than the company's other figures. The latest Gross Profit is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$1.30M
Year ended 2023-12-31
-70.1%
3-year compound annual growth
-37.2%
5-year compound annual growth
-15.3%
10-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $1.30M | -98.1% | 2024-03-29, From 2023-01-01 |
| 2022-12-31 | $68.57M | n/m | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | $1.17M | -97.6% | 2023-04-07, From 2021-01-01 |
| 2020-12-31 | $48.90M | +12.9% | 2022-03-23, From 2020-01-01 |
| 2019-12-31 | $43.31M | +224.1% | 2022-03-23, From 2019-01-01 |
| 2018-12-31 | $13.36M | -5.5% | 2021-03-04, From 2018-01-01 |
| 2017-12-31 | $14.14M | -6.8% | 2020-02-24, From 2017-01-01 |
| 2016-12-31 | $15.17M | -3.0% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $15.64M | +37.7% | 2018-02-23, From 2015-01-01 |
| 2014-12-31 | $11.35M | +66.6% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $6.82M | +176.0% | 2016-02-26, From 2013-01-01 |
| 2012-12-31 | $2.47M | +116.5% | 2015-03-12, From 2012-01-01 |
| 2011-12-31 | $1.14M | n/a | 2014-03-05, From 2011-01-01 |